Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Comparing cemented hip cups for better stability after surgery

Official title: Migration in Total Hip Arthroplasty with a Cemented BiMobile Cup: Better Stability with More Cement? (Be-Mobile)

Run by JointResearch · NCT04049279 · Data updated 2026-11-12

This study is testing if using more cement with different sizes of hip cups can help people who have hip surgery feel more stable and reduce the chance of their hip dislocating.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment75 (estimated)
SponsorJointResearch
Academic / other
Locations1 site (Amsterdam)
StatusRecruiting
StartedJanuary 1, 2019
Main results expectedMay 1, 2026
Study endsMay 1, 2029
Registry record updatedFebruary 28, 2025
Trial IDNCT04049279 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are male patients aged 70 and older and female patients aged 65 and older who require elective primary cemented total hip arthroplasty.

Probably not a fit

Patients who are morbidly obese, have other joint replacements planned within a year, or have systemic disorders affecting bone health may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the early migration of a cemented BiMobile cup in total hip arthroplasty by comparing two different cup sizes and their associated cement mantles. It is a prospective, single-center, blinded randomized controlled trial involving patients undergoing primary cemented total hip arthroplasty. The study will assess whether increasing the amount of cement used for fixation improves stability and reduces the risk of dislocation, a common complication after hip surgery. Additionally, the BiMobile cup's performance will be compared to the Avantage cup, which uses a standard cup size.

Why it matters

Potential benefit: If successful, this study could lead to improved stability and reduced dislocation rates in patients undergoing total hip arthroplasty.

How similar studies have gone: Other studies have explored similar approaches with dual mobility cups, but this specific comparison of cement mantle sizes is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient requiring an elective primary cemented THA.
* Male patient ≥70 years old and female patient ≥65 years old.
* Ability and willingness to follow instructions and to return for follow-up evaluations.
* The patient is able to understand the meaning of the study and is willing to sign informed consent.
* Understanding the Dutch language.

Exclusion Criteria:

* The patient is morbidly obese, defined as Body Mass Index (BMI) of ≥ 40.
* The patient is expected to need lower limb joint replacement for another joint within one year.
* The patient has a systemic or metabolic disorder leading to progressive bone deterioration.
* The patient has a deformity or disease located in other joints than the hip that needs surgery and that is limiting their ability to walk.
* The patient has an active or suspected latent infection in or around the hip joint.
* The patient's bone stock is compromised by a disease or infection which cannot provide adequate support and/or fixation to the prosthesis.
* The patient is unable or unwilling to sign informed consent for this study.
* The patient is deemed unsuitable for participation in the study based on the investigator's judgment.

Where it's running

  • Olvg
    Amsterdam, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.